Ovid Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	226	228	131	219	147	198	60	243
Market Cap Growth	-	73.64%	-40.04%	49.16%	-26.16%	232.60%	-75.43%	-
Enterprise Value	167	166	17	29	75	122	18	156
PE Ratio	-4.35	-4.35	-2.42	1.78	-1.81	-3.28	-1.15	-3.75
PS Ratio	583.09	581.04	87.22	1.05	11.61	-	-	-
PB Ratio	2.60	2.59	0.99	1.22	3.36	2.83	1.54	2.91
P/FCF Ratio	-4.97	-4.97	-2.32	1.85	-2.83	-3.88	-1.31	-7.71
P/OCF Ratio	-4.97	-4.97	-2.37	1.84	-2.84	-3.88	-1.31	-7.72
EV/Sales Ratio	425.41	423.36	11.09	0.14	5.90	-	-	-
EV/EBITDA Ratio	-3.27	-3.27	-0.32	0.23	-0.92	-2.02	-0.35	-2.41
EV/EBIT Ratio	-3.17	-3.17	-0.31	0.23	-0.92	-2.01	-0.35	-2.40
EV/FCF Ratio	-3.62	-3.62	-0.30	0.24	-1.44	-2.38	-0.40	-4.94
Debt / Equity Ratio	0.52	0.52	0.13	-	-	-	-	-
Debt / EBITDA Ratio	-0.91	-0.91	-0.31	-	-	-	-	-
Debt / FCF Ratio	-1.00	-1.00	-0.29	-	-	-	-	-
Quick Ratio	9.39	9.39	18.73	12.82	3.27	7.39	4.76	14.47
Current Ratio	9.55	9.55	18.79	12.87	3.39	7.58	5.01	14.71
Asset Turnover	0.00	0.00	0.01	0.97	0.18	0	0	0
Return on Equity (ROE)	-49.80%	-49.80%	-36.60%	61.10%	-171.30%	-119.30%	-93.70%	-81.10%
Return on Assets (ROA)	-38.20%	-38.20%	-31.50%	57.30%	-118.00%	-99.50%	-81.40%	-75.70%
Return on Capital (ROIC)	-44.31%	-44.31%	-37.33%	68.36%	-186.63%	-87.70%	-136.40%	-77.91%
Earnings Yield	-22.92%	-23.00%	-41.33%	56.20%	-55.30%	-30.47%	-87.12%	-26.69%
FCF Yield	-20.06%	-20.13%	-43.07%	54.18%	-35.29%	-25.78%	-76.42%	-12.98%
Buyback Yield / Dilution	-0.22%	-0.22%	-3.46%	-16.45%	-49.04%	-59.22%	-27.33%	-96.62%
Total Shareholder Return	-0.22%	-0.22%	-3.46%	-16.45%	-49.04%	-59.22%	-27.33%	-96.62%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).